Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Mpower an initiative of Aditya Birla Education Trust works in the space of Mental health
The generous donation includes multiple medical equipments
The company will develop and produce premixes for human nutrition applications
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
